- Home
- BCYC vs FFA Comparison
BCYC vs FFA Comparison
Compare BCYC & FFA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BCYC | FFA |
|---|---|---|
| Founded | 2009 | 2004 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 456.4M | 429.4M |
| IPO Year | 2019 | N/A |
Fundamental Metrics
Financial Performance| Metric | BCYC | FFA |
|---|---|---|
| Price | $5.36 | $22.22 |
| Analyst Decision | Buy | |
| Analyst Count | 10 | 0 |
| Target Price | ★ $19.10 | N/A |
| AVG Volume (30 Days) | ★ 376.3K | 26.1K |
| Earning Date | 02-20-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 6.72% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $28,339,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $5.27 | $15.84 |
| 52 Week High | $13.11 | $19.30 |
Technical Indicators
Market Signals| Indicator | BCYC | FFA |
|---|---|---|
| Relative Strength Index (RSI) | 33.23 | 57.19 |
| Support Level | $5.27 | $21.64 |
| Resistance Level | $5.95 | $22.31 |
| Average True Range (ATR) | 0.37 | 0.23 |
| MACD | -0.11 | 0.02 |
| Stochastic Oscillator | 6.00 | 85.07 |
Price Performance
Historical ComparisonAbout BCYC Bicycle Therapeutics plc
Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC. The company has two segments: the United Kingdom and the United States. It derives maximum revenue from United States.
About FFA First Trust Enhanced Equity Income Fund
First Trust Enhanced Equity Income Fund is a diversified, closed-end management investment company. Its investment objective is to provide high level of current income and gains and, to a lesser extent, capital appreciation. The Fund pursues its investment objective by investing in a diversified portfolio of equity securities.